HCWB · HCW Biologics Inc. Common Stock
View on chartInsiders & Stakes
| Hing C. Wong Chief Executive Officer | ▲ Buy | Open Market | 125,845 Shares held | 7/29/2026 | View profile |
| Peter Rhode See Remarks | ▲ Buy | Option Exercise | 77,500 Shares held | 12/11/2023 | View profile |
| Rebecca Byam Chief Financial Officer | ▲ Buy | Open Market | 57,245 Shares held | 5/22/2026 | View profile |
| Jiao Jin-an VP of Development | ▲ Buy | Option Exercise | 45,141 Shares held | 5/31/2022 | View profile |
| Scott T. Garrett Director | ▲ Buy | Open Market | 41,644 Shares held | 7/29/2026 | View profile |
| Lisa M. Giles Director | ▲ Buy | Grant | 35,815 Shares held | 2/20/2024 | View profile |
| Lee Flowers SVP of Business Development | ▲ Buy | Open Market | 8,691 Shares held | 7/29/2026 | View profile |
| Gary M. Winer Director | ▲ Buy | Open Market | 4,075 Shares held | 5/16/2025 | View profile |
| Rick S. Greene Director | ▲ Buy | Open Market | 2,066 Shares held | 5/8/2025 | View profile |
| Medmira Capital Ltd. 10% Owner | ▼ Sell | Other | 0 Shares held | 9/15/2021 | View profile |
Transaction History
| Hing C. Wong | ▲ Buy | Open Market | 23,210 | $60K | 7/29/2026 |
| Lee Flowers | ▲ Buy | Open Market | 7,736 | $20K | 7/29/2026 |
| Scott T. Garrett | ▲ Buy | Open Market | 7,736 | $20K | 7/29/2026 |
| Scott T. Garrett | ▲ Buy | Open Market | 177,936 | $250K | 5/22/2026 |
| Hing C. Wong | ▲ Buy | Open Market | 113,879 | $160K | 5/22/2026 |
| Rebecca Byam | ▲ Buy | Open Market | 14,235 | $20K | 5/22/2026 |
| Scott T. Garrett | ▲ Buy | Open Market | 13,423 | $100K | 5/16/2025 |
| Hing C. Wong | ▲ Buy | Open Market | 8,054 | $60K | 5/16/2025 |
| Gary M. Winer | ▲ Buy | Open Market | 1,342 | $10K | 5/16/2025 |
| Gary M. Winer | ▲ Buy | Open Market | 2,308 | $60K | 5/8/2025 |
| Hing C. Wong | ▲ Buy | Open Market | 92,500 | $2.4M | 5/8/2025 |
| Scott T. Garrett | ▲ Buy | Open Market | 5,385 | $140K | 5/8/2025 |
| Rebecca Byam | ▲ Buy | Open Market | 8,462 | $220K | 5/8/2025 |
| Lee Flowers | ▲ Buy | Open Market | 962 | $25K | 5/8/2025 |
| Rick S. Greene | ▲ Buy | Open Market | 962 | $25K | 5/8/2025 |
| Rebecca Byam | ▲ Buy | Grant | 760,714 | $1.1M | 2/20/2024 |
| Scott T. Garrett | ▲ Buy | Grant | 142,858 | $200K | 2/20/2024 |
| Lee Flowers | ▲ Buy | Grant | 71,429 | $100K | 2/20/2024 |
| Hing C. Wong | ▲ Buy | Grant | 739,288 | $1.0M | 2/20/2024 |
| Rick S. Greene | ▲ Buy | Grant | 35,714 | $50K | 2/20/2024 |
| Lisa M. Giles | ▲ Buy | Grant | 35,715 | $50K | 2/20/2024 |
| Peter Rhode | ▲ Buy | Option Exercise | 14,000 | $2K | 12/11/2023 |
| Lee Flowers | ▲ Buy | Option Exercise | 7,501 | $1K | 12/8/2023 |
| Peter Rhode | ▲ Buy | Option Exercise | 15,000 | $2K | 11/17/2023 |
| Rebecca Byam | ▲ Buy | Option Exercise | 47,249 | $7K | 10/19/2023 |
| Hing C. Wong | ▲ Buy | Open Market | 1,800 | $4K | 9/14/2023 |
| Gary M. Winer | ▲ Buy | Open Market | 162 | $337 | 9/14/2023 |
| Gary M. Winer | ▲ Buy | Open Market | 879 | $2K | 9/14/2023 |
| Gary M. Winer | ▲ Buy | Open Market | 500 | $1K | 9/13/2023 |
| Gary M. Winer | ▲ Buy | Open Market | 46 | $92 | 9/13/2023 |
| Rebecca Byam | ▲ Buy | Open Market | 5,000 | $10K | 9/13/2023 |
| Gary M. Winer | ▲ Buy | Open Market | 500 | $1K | 9/12/2023 |
| Rebecca Byam | ▲ Buy | Open Market | 5,000 | $10K | 9/12/2023 |
| Rebecca Byam | ▲ Buy | Open Market | 5,000 | $10K | 9/11/2023 |
| Gary M. Winer | ▲ Buy | Open Market | 99 | $203 | 9/11/2023 |
| Rebecca Byam | ▲ Buy | Open Market | 5,000 | $10K | 9/8/2023 |
| Gary M. Winer | ▲ Buy | Open Market | 1 | $2 | 9/8/2023 |
| Rebecca Byam | ▲ Buy | Open Market | 5,000 | $10K | 9/7/2023 |
| Gary M. Winer | ▲ Buy | Open Market | 63 | $123 | 9/7/2023 |
| Rebecca Byam | ▲ Buy | Open Market | 5,000 | $10K | 9/6/2023 |
| Gary M. Winer | ▲ Buy | Open Market | 400 | $700 | 9/5/2023 |
| Rebecca Byam | ▲ Buy | Open Market | 20,000 | $41K | 6/9/2023 |
| Lee Flowers | ▲ Buy | Option Exercise | 5,356 | $750 | 6/8/2023 |
| Lee Flowers | ▲ Buy | Open Market | 10,000 | $22K | 6/8/2023 |
| Rebecca Byam | ▲ Buy | Open Market | 4,696 | $10K | 6/8/2023 |
| Rebecca Byam | ▲ Buy | Open Market | 20,000 | $41K | 6/7/2023 |
| Rebecca Byam | ▲ Buy | Open Market | 19,062 | $35K | 6/6/2023 |
| Rebecca Byam | ▲ Buy | Open Market | 20,000 | $33K | 6/5/2023 |
| Hing C. Wong | ▲ Buy | Open Market | 800 | $1K | 6/2/2023 |
| Hing C. Wong | ▲ Buy | Open Market | 800 | $1K | 6/1/2023 |
| Hing C. Wong | ▲ Buy | Open Market | 2,000 | $3K | 5/31/2023 |
| Gary M. Winer | ▲ Buy | Open Market | 500 | $750 | 5/31/2023 |
| Gary M. Winer | ▲ Buy | Open Market | 850 | $1K | 5/30/2023 |
| Hing C. Wong | ▲ Buy | Open Market | 3,000 | $5K | 5/30/2023 |
| Rebecca Byam | ▲ Buy | Open Market | 20,000 | $33K | 5/26/2023 |
| Rebecca Byam | ▲ Buy | Open Market | 20,000 | $32K | 5/25/2023 |
| Rebecca Byam | ▲ Buy | Open Market | 20,000 | $32K | 5/24/2023 |
| Rebecca Byam | ▲ Buy | Open Market | 5,036 | $8K | 5/23/2023 |
| Rebecca Byam | ▲ Buy | Open Market | 33,450 | $51K | 5/22/2023 |
| Rebecca Byam | ▲ Buy | Option Exercise | 33,750 | $5K | 11/2/2022 |
| Rebecca Byam | ▲ Buy | Open Market | 15,000 | $39K | 9/14/2022 |
| Rebecca Byam | ▲ Buy | Open Market | 15,000 | $39K | 9/13/2022 |
| Rebecca Byam | ▲ Buy | Open Market | 15,000 | $40K | 9/12/2022 |
| Hing C. Wong | ▲ Buy | Open Market | 6,000 | $16K | 9/9/2022 |
| Hing C. Wong | ▲ Buy | Open Market | 4,000 | $11K | 9/8/2022 |
| Hing C. Wong | ▲ Buy | Open Market | 6,000 | $15K | 9/7/2022 |
| Hing C. Wong | ▲ Buy | Open Market | 4,000 | $10K | 9/2/2022 |
| Rebecca Byam | ▲ Buy | Open Market | 10,000 | $26K | 8/31/2022 |
| Rebecca Byam | ▲ Buy | Open Market | 7,200 | $18K | 8/30/2022 |
| Rebecca Byam | ▲ Buy | Open Market | 10,000 | $26K | 8/29/2022 |
| Rebecca Byam | ▲ Buy | Open Market | 10,000 | $25K | 8/26/2022 |
| Rebecca Byam | ▲ Buy | Open Market | 40,300 | $105K | 8/25/2022 |
| Rebecca Byam | ▲ Buy | Open Market | 50,000 | $125K | 8/24/2022 |
| Rebecca Byam | ▲ Buy | Open Market | 58,856 | $145K | 6/14/2022 |
| Rebecca Byam | ▲ Buy | Open Market | 7,596 | $16K | 6/13/2022 |
| Hing C. Wong | ▲ Buy | Open Market | 1,520 | $3K | 6/10/2022 |
| Gary M. Winer | ▲ Buy | Open Market | 1,500 | $3K | 6/10/2022 |
| Gary M. Winer | ▲ Buy | Open Market | 1,000 | $2K | 6/9/2022 |
| Hing C. Wong | ▲ Buy | Open Market | 2,000 | $4K | 6/9/2022 |
| Gary M. Winer | ▲ Buy | Open Market | 1,000 | $2K | 6/8/2022 |
| Hing C. Wong | ▲ Buy | Open Market | 1,000 | $2K | 6/7/2022 |
| Gary M. Winer | ▲ Buy | Open Market | 1,000 | $2K | 6/7/2022 |
| Gary M. Winer | ▲ Buy | Open Market | 1,000 | $2K | 6/6/2022 |
| Rick S. Greene | ▲ Buy | Open Market | 4,800 | $10K | 6/2/2022 |
| Jiao Jin-an | ▲ Buy | Option Exercise | 12,856 | $2K | 5/31/2022 |
| Jiao Jin-an | ▲ Buy | Option Exercise | 1,714 | $360 | 5/31/2022 |
| Peter Rhode | ▲ Buy | Option Exercise | 1,714 | $360 | 1/14/2022 |
| Peter Rhode | ▲ Buy | Option Exercise | 1 | $0 | 1/14/2022 |
| Jiao Jin-an | ▲ Buy | Open Market | 10,000 | $24K | 12/6/2021 |
| Lee Flowers | ▲ Buy | Option Exercise | 4,285 | $600 | 12/1/2021 |
| Rebecca Byam | ▲ Buy | Option Exercise | 27,000 | $4K | 11/23/2021 |
| Medmira Capital Ltd. | ▼ Sell | Other | 3,587,659 | $0 | 9/15/2021 |
| Hing C. Wong | ▲ Buy | Open Market | 3,830 | $15K | 8/31/2021 |
| Hing C. Wong | ▲ Buy | Open Market | 6,000 | $24K | 8/30/2021 |
| Hing C. Wong | ▲ Buy | Open Market | 6,000 | $23K | 8/27/2021 |
| Hing C. Wong | ▲ Buy | Open Market | 6,500 | $25K | 8/26/2021 |
| Rick S. Greene | ▲ Buy | Open Market | 3,611 | $15K | 8/25/2021 |
| Lee Flowers | ▲ Buy | Open Market | 5,605 | $22K | 8/23/2021 |
| Lee Flowers | ▲ Buy | Open Market | 7,853 | $32K | 8/20/2021 |
| Lee Flowers | ▲ Buy | Open Market | 10,532 | $45K | 8/19/2021 |
| Rebecca Byam | ▲ Buy | Open Market | 10,000 | $44K | 8/19/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
HCW Biologics Included in After-Market Movers List
HCW Biologics was listed among healthcare stocks moving in Friday's after-market session. The stock is currently trading near its 52-week low, with technical indicators showing oversold conditions. This inclusion highlights recent price volatility, though no specific catalyst for the move was detailed in the provided news.
HCW Biologics Included in After-Market Movers List. HCW Biologics was listed among healthcare stocks moving in Friday's after-market session. The stock is currently trading near its 52-week low, with technical indicators showing oversold conditions. This inclusion highlights recent price volatility, though no specific catalyst for the move was detailed in the provided news.